**Question:** Which of the following indicates 'flipping effect'?

A. ACE inhibition
B. Beta-blockade
C. Angiotensin II receptor blocker (ARB)
D. Calcium channel blocker

**Core Concept:** The concept being tested in this question is the concept of a "flipping effect", which refers to a situation where an initial therapeutic effect is observed with a drug, but subsequent administration of the same drug results in a different effect or no effect at all. This phenomenon can occur due to changes in receptor density or affinity, altered drug distribution, or other factors.

**Why the Correct Answer is Right:** The correct answer, C. Angiotensin II receptor blocker (ARB), illustrates the flipping effect due to the following reasons:

1. **Angiotensin II receptor blockers (ARBs):** Angiotensin II is a potent vasoconstrictor that contributes to vasoconstriction, aldosterone secretion, and sodium retention. By blocking Angiotensin II receptors, ARBs help in vasodilation, reduced aldosterone secretion, and decreased sodium retention.

2. **Flipping effect:** In some cases, long-term use of ARBs can lead to a flipping effect. This means that subsequent administration of the same ARB may result in reduced efficacy or even worsening of hypertension due to downregulation of AT1 receptors (Angiotensin II receptors).

**Why Each Wrong Option is Incorrect:**

1. ACE inhibitors (A) and beta-blockers (B) do not exhibit the flipping effect as they primarily act by blocking different pathways (ACE inhibition for ACE inhibitors and beta-blockade for beta-blockers).

2. Calcium channel blockers (D) do not demonstrate flipping effect as they work by blocking calcium channels, which is a necessary step in the process of myocardial contraction and vascular smooth muscle contraction.

**Clinical Pearl:** Understanding the flipping effect with ARBs is crucial for a proper selection of pharmacotherapy and monitoring of patients' responses in clinical practice. This phenomenon highlights the need for careful adjustment of drug dosages and monitoring of blood pressure response to ensure optimal therapeutic outcomes.